In Vitro Fertilization Device Market Key Manufacturers - Irvine Scientific, Cooper Surgical, Inc., Genea Biomedx, Auxogyn, Inc., Oxford Gene Technology, OvaScience, Inc., Vitrolife AB, Cook Medical, Inc. Etc. Till 2022

In Vitro Fertilization Device Market – Key Players

Some of the key players in this market are: EMD Serono, Inc., Irvine Scientific, Cooper Surgical, Inc., hermo Fisher Scientific, Inc., Genea Biomedx, Auxogyn, Inc., Oxford Gene Technology and OvaScience, Inc Vitrolife AB, Cook Medical, Inc., Esco Micro Pte. Ltd and others.

In Vitro Fertilization Device Market - Segments

The global in vitro fertilization market report segments the global market on the basis of type, product, end user, and region.

By type, the global in vitro fertilization market is segmented into intrauterine insemination, in-vitro fertilization, intracytoplasmic sperm injection, and IVF using donor eggs. The share of intracytoplasmic sperm injection in the global IVF market is likely to remain strong over the forecast period, as the method has become extremely popular in recent years.

By product, the global in vitro fertilization market is segmented into devices and reagents. The devices segment is sub-segmented into imaging systems, sperm separation systems, ovum aspiration pumps, cerosystem, and micromanipulators. The reagents segment is divided into embryo culture media, cryopreservation media, sperm processing media, and ovum processing media.

By end user, the IVF market is segmented into fertility clinics, hospitals, and clinical research centers.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2289

In Vitro Fertilization Device Market – Overview

The Global Market for In Vitro Fertilization (IVF) Device is projected to surge at a CAGR of 11.7% during the forecast period (2016-2022), as analyzed by experts from Market Research Future (MRFR). Rise in infertility rates, surge in the availability of technologically advanced products, steady success of the IVF procedure, and a rise in fertility tourism worldwide has helped this market gain prominence worldwide.

The demand for IVF procedures in surgical centers is on a rise due to these centers providing facilities for surgical sperm retrieval and fertility enhancing surgeries such as tubal surgery, tubal reversal surgery, and various other techniques that can eventually lead to conception. The rise in the number of fertility clinics also allows couples to choose clinics based on their convenience, thus pushing the demand for IVF devices globally. Also, increasing awareness amongst couples facing infertility issues seek medical help, which in turn fuels the IVF market growth.

However, device related issues and controversies with regard to in-vitro fertilization devices are anticipated to present challenges to the market growth during the forecast period. On the other hand, government funding for egg/sperm freezing processes which brings down the chances of multiple pregnancies and technological advancement which assists in pre-identification of any genetic disorder can foster market growth. Hectic schedule, changing lifestyle, stress, and tension can create issues of infertility. This can create opportunities for the market.

IVF trends are driving the market immensely, which include usage of IVF for prevention of diseases, increase in availability of cheap 23andMe type genetic screening for prevention of passing on of genetic diseases, and progressing techniques aimed at oocyte (egg) factor infertility to rejuvenate the eggs of the patient.

Industry News:

In September 2018, it was revealed in Australian Financial review Friday that the Asian investment firm Aldworth Management, Hong Kong-listed financial services and wealth company Mason Group and Chinese company WeDoctor which is backed by Tencent Group Holdings Ltd. are have teamed up to buy Genea, Australia's third-largest in vitro fertilization services provider based in Sydney.

In January 2018, A team of researchers from Worcester Polytechnic Institute (WPI) and Stanford University, developed a SPARTAN sperm sorting device that Could Improve IVF Success. The device uses an “obstacle course” to sort and select faster and healthier sperm cells which can be used in IVF treatment.

In November 2016, The Cooper Companies, Inc. announced the acquisition of Wallace, the in-vitro fertilization (IVF) segment of Smiths Medical by CooperSurgical. The acquisition provides strategic benefit to CooperSurgical’s existing IVF portfolio as Wallace brings the gold standard of embryo transfer catheters along with some of the premier products like oocyte retrieval needles.

In June 2016, CooperSurgical acquired Reprogenetics UK of Oxford, United Kingdom. Reprogenetics UK is a terrific addition to CooperSurgical’s industry leading ART portfolio of IVF and genetic testing solutions.

In Vitro Fertilization Device Market - Regional Analysis

Europe is likely to be a major contributor to the global IVF market over the forecast period. The medical research sector in Europe is highly advanced and houses well-developed IVF procedures. Medical tourism in Europe has also taken off in a big way, with countries such as the Czech Republic emerging as a popular destination for Americans looking to obtain IVF treatments at a cheaper rate. The U.K., France, and Germany are likely to play key roles in the development of the in vitro fertilization market in Europe over the forecast period.

The Asia Pacific in vitro fertilization market is also likely to take off spectacularly over the forecast period due to the growing medical tourism in the region, including medical tourism for fertility treatments, and growing prevalence of infertility problems in APAC countries themselves. The growing population of APAC countries is likely to provide fertility clinics with a rich market in the coming years, leading to steady growth of the in vitro fertilization market over the forecast period.

Browse Complete 80 Pages Premium Research Report Enabled with 150 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/in-vitro-fertilization-market-2289

North America is also likely to remain a steady contributor to the global in vitro fertilization market over the forecast period due to the growing prevalence of infertility conditions among North American men and women.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.